Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 6
2013 25
2014 27
2015 41
2016 35
2017 28
2018 23
2019 24
2020 21
2021 5
2022 6
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Results by year

Filters applied: . Clear all
Page 1
Radium 223 dichloride for prostate cancer treatment.
Deshayes E, Roumiguie M, Thibault C, Beuzeboc P, Cachin F, Hennequin C, Huglo D, Rozet F, Kassab-Chahmi D, Rebillard X, Houédé N. Deshayes E, et al. Drug Des Devel Ther. 2017 Sep 6;11:2643-2651. doi: 10.2147/DDDT.S122417. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28919714 Free PMC article. Review.
Targeted α-Therapy.
Brechbiel MW. Brechbiel MW. Cancer Biother Radiopharm. 2020 Aug;35(6):397. doi: 10.1089/cbr.2020.29008.mbr. Epub 2020 Jun 5. Cancer Biother Radiopharm. 2020. PMID: 32503377 No abstract available.
Radium-223 dichloride in clinical practice: a review.
Florimonte L, Dellavedova L, Maffioli LS. Florimonte L, et al. Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1896-909. doi: 10.1007/s00259-016-3386-5. Epub 2016 Apr 28. Eur J Nucl Med Mol Imaging. 2016. PMID: 27121689 Review.
Radium Ra 223 dichloride injection: U.S. Food and Drug Administration drug approval summary.
Kluetz PG, Pierce W, Maher VE, Zhang H, Tang S, Song P, Liu Q, Haber MT, Leutzinger EE, Al-Hakim A, Chen W, Palmby T, Alebachew E, Sridhara R, Ibrahim A, Justice R, Pazdur R. Kluetz PG, et al. Clin Cancer Res. 2014 Jan 1;20(1):9-14. doi: 10.1158/1078-0432.CCR-13-2665. Epub 2013 Nov 4. Clin Cancer Res. 2014. PMID: 24190979 Clinical Trial.
Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment-Japanese Ra-223 Therapy in Prostate Cancer using Bone Scan Index (J-RAP-BSI) Trial.
Kitajima K, Igeta M, Kuyama J, Kawahara T, Suga T, Otani T, Sugawara S, Kono Y, Tamaki Y, Seko-Nitta A, Ishiwata Y, Ito K, Toriihara A, Watanabe S, Hosono M, Miyake H, Yamamoto S, Narita M, Daimon T, Yamakado K. Kitajima K, et al. Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1487-1498. doi: 10.1007/s00259-022-06082-3. Epub 2022 Dec 21. Eur J Nucl Med Mol Imaging. 2023. PMID: 36539508
Radium-223 dichloride: a new paradigm in the treatment of prostate cancer.
Anido Herranz U, Fernández Calvo O, Afonso Afonso FJ, Rodríguez Martínez de Llano S, Lázaro Quintela M, León Mateos L, Vázquez Estévez S, Antón Aparicio LM. Anido Herranz U, et al. Expert Rev Anticancer Ther. 2015 Mar;15(3):339-48. doi: 10.1586/14737140.2015.999045. Epub 2015 Jan 2. Expert Rev Anticancer Ther. 2015. PMID: 25555355 Free article. Review.
210 results